We’re a programmable clinical-stage cell therapy company focused on the realization of solid tumor cell therapies. Our purpose is very clear: defeat cancer.
Joined October 2019
- Tweets201
- Following65
- Followers1.7K
- Likes14
CEO @KDrazan will join a panel tomorrow, March 4, 3:30-4:30pm, at #PMWC26, where they will discuss Gene Editing & Synthetic Biology for Therapy.
More: bit.ly/40DVqfx #Biotech #Oncology
Today at the Evolution Summit, ArsenalBio’s Farah Anwar will share insights on CAR-T cell therapy and its potential to redefine the future of personalized cancer treatment.
More here: bit.ly/3LIZpn9 #CancerResearch
This Wednesday, ArsenalBio’s Farah Anwar will join a panel of clinical trial experts to share strategies for balancing scientific rigor, operational efficiency, and the patient experience.
More on the webinar: bit.ly/48Hyn7a #celltherapy #clinicaltrials
Heading to @AdTherapiesConf USA 2025 this week? Check out one of the sessions where Christopher Murriel will share insights on #celltherapy development. bit.ly/3X1QJdU #adtherapies #cancerresearch
We’re gearing up for #SITC2025! We will share the latest research on our lead investigative cell therapy intended for mCRPC, CAR T cell therapy design, and our foundation model predicting targets for overcoming T cell exhaustion. Join us Nov 7–9: bit.ly/3JHY0wb
We’re presenting at the @CAR_TCell Summit tomorrow on the development of our T cell therapy intended for metastatic prostate cancer and maintaining high potency in our development of cell therapy products. bit.ly/3KBpuDJ
#CellTherapy #CancerResearch #ProstateCancer
We’re developing a CAR-T cell therapy as a potential treatment for metastatic prostate cancer, for which new and more effective treatments are urgently needed. Stay tuned as we advance this program toward the clinic. More: bit.ly/3VqLxzg #ProstateCancer #CancerResearch
Join ArsenalBio scientist Sophia Phillips on July 17 at the Process Development for Cell Therapies Summit for a case study on overcoming process development challenges in solid tumor-targeting cell therapies. bit.ly/40hBPCm
#CellTherapy #DrugDevelopment
ALT Headshot of SOPHIA PHILLIPS of Arsenal Bio Process Development for Cell Therapies Summit Case Study: Overcoming Process Development Challenges in Solid Tumor-Targeting Cell Therapies Thursday, July 17, 2025 | 12:30pm ET | Boston SOPHIA PHILLIPS Scientist I Process Development
On July 15 at the Process Development for Cell Therapies Summit, ArsenalBio scientist Max Lee will present during a workshop focused on implementing cutting-edge technology with phase-appropriate strategies. bit.ly/40agF90
#CellTherapy #Drug Development
